The interaction of mucosal lymphocytes and intestinal epithelial cells is thought to be important in regulating immune response in the intestinal mucosa, but conclusive evidence is limited. Here we demonstrate the expression of IL-7 mRNA in human intestinal mucosa by combined reverse transcription PCR and Southern blot hybridization. Immunohistochemistry and in situ hybridization confirm the presence of IL-7 in intestinal epithelial cells, especially in epithelial goblet cells. Moreover, IL-7 receptor expression in mucosal lymphocytes is demonstrated by immunohistochemistry and in situ hybridization, as well as by Southern blot and flow cytometric analysis of freshly isolated lamina propria lymphocytes. In contrast, IL-7 receptor could not be detected in the cell surface of freshly isolated PBLs. The functional activity of IL-7 receptor is demonstrated by the utility of recombinant IL-7 to stimulate the growth of lamina propria lymphocytes, and conversely inhibit CD3-dependent proliferation of these cells. In contrast, 1L-7 caused no significant increase in DNA synthesis and cell numbers when added to PBLs. These findings suggest that human intestinal epithelial cells and epithelial goblet cells produce IL-7, and locally produced 1L-7 may serve as a potent regulatory factor for intestinal mucosal lymphocytes. (J. Clin. Invest 1995Invest . 95:2945Invest -2953 Key words: interleukin 7 receptor * and in revisedform 21 February 1995.
Introduction
The intestinal mucosa is continuously exposed to a variety of foreign antigens. Intestinal mucosal lymphocytes, the intraepi-thelial lymphocytes (IELs),' and lamina propria lymphocytes (LPLs) , located adjacent to the intestinal lumen and mucosal barrier, may initiate local immune responses to those exogenous antigens (1) (2) (3) , monitor intestinal enterocytes, and respond to nonpolymorphic molecules such as CDld expressed on the surface of epithelial cells (4, 5) . These mucosal lymphocytes may serve a critical role in the mucosal immune system by providing immune surveillance of epithelial cells (6) . However, little is known about the precise mechanism by which functional differentiation and proliferation of these cells occurs in the intestinal mucosa. Although recent studies have shown that cytokines released from mucosal mononuclear cells may affect intestinal epithelial cell differentiation (7, 8) , the signals originating from epithelial cells that may regulate mucosal lymphocytes are as yet undefined. IL-7 is a stromal cell-derived pleiotropic cytokine with lymphoid precursor cell growth-promoting activity (9) (10) (11) (12) (13) (14) . Recent studies have demonstrated IL-7 mRNA expression in bone marrow stromal cells, thymus, spleen, liver, kidney, and keratinocytes ( 15, 16) . We sought to investigate the role of IL-7 in the growth and differentiation of the intestinal mucosal lymphocytes. We have done this by assessing the expression of IL-7 and IL-7 receptor (17, 18) in the human intestinal mucosa. Here we report IL-7 mRNA expression and IL-7 protein production in the colonic epithelial cells and epithelial goblet cells. These results, in concert with the findings that IL-7 receptors are expressed by mucosal lymphocytes, suggest that IL-7 produced in the intestinal epithelium may serve as a regulatory factor for the intestinal mucosal lymphocytes.
Methods
Normal human intestinal mucosa from biopsied tissues. Normal intestinal mucosa was obtained from the biopsied specimens of colonic tissues from normal appearing rectal and sigmoid colonic mucosa of seven healthy unrelated adult males undergoing screening sigmoidoscopy. Small intestinal biopsies from the third portion of the duodenum and stomach biopsies were obtained in five individuals with a normal upper intestinal endoscopy. Mucosal biopsies from the colon, small intestine, and stomach were 2-3 mm in size. Histopathological examination revealed no malignancy and inflammation in the gastrointestinal tissues we used. The mucosa was prepared immediately after stripping from the underlying submucosa by blunt dissection. PBLs, obtained at the time of intestinal biopsy, were separated from whole blood. All experiments were approved by the Keio University Hospital Committee on Human Subjects, Tokyo, Japan.
Cell lines. We used a human liver adenocarcinoma cell line, SK-HEP-1 (American Type Culture Collection [ATCC], Rockville, MD) as a positive control cell line for mRNA expression of IL-7, because it was used to clone the cDNA for human IL-7 (10). SV40-transformed human lung cell line, WI-26 VA4 (ATCC) was used as a positive control cell line for IL-7 receptor mRNA, because it was shown to express high levels of human IL-7 receptor and used to clone the cDNA for human IL-7 receptor (18) . Two human Burkitt's lymphoma cell lines, Daudi (as a positive control) and Raji (as a negative control) (ATCC), were used for detecting of IL-7 receptor cell surface expression by flow cytometric analysis. Daudi was shown to express IL-7 receptor on the cell surface but Raji did not (19) . The human colonic epithelial cell lines HT29 and Caco-2 were obtained from ATCC. The HT29-18-N2 subclone exhibits intestinal epithelial goblet cell phenotype in the subconfluent or postconfluent state, as assessed by morphological differentiation and expression of mucin glycoprotein (20) . The Caco-2 cell line undergoes enterocytic differentiation, but does not exhibit goblet cell phenotype. Human hepatocyte cell line, Chang, was kindly provided by K. Toda, Kitasato Institute Hospital, Tokyo, Japan. These cell lines were tested for the expression of IL-7 receptor mRNA.
PCR and Southern blot hybridization for IL-7 and IL-7 receptor mRNA. Cytoplasmic RNA was prepared from human intestinal mucosa and cell lines using the RNAzol (Biotecx Laboratories, Inc., Houston, TX). First-strand cDNA was synthesized from 2 gg of total RNA with 1 Ag oligo (dT) primer and 400 U11l Moloney murine leukemia virus reverse transcriptase (Perkin-Elmer Cetus Instruments, Norwalk, CT) by using SuperScript Preamplification System (GIBCO BRL, Gaithersburg, MD) in 20 Il of the reaction mixture (21) . All the PCR primers for human IL-7, IL-7 receptor, and G3PDH (glyceraldehyde 3-phosphate dehydrogenase) (as a house-keeping gene) gene-specific amplification of cDNA in the analysis of mRNA expression by reverse transcription-PCR were purchased from Clontech Laboratories, Inc. (Palo Alto, CA). The sequences for IL-7 PCR primers were: 5 'primer; 5 '-ATGTT-CCATGTITCTTYTIAGGTATATCT-3 '; 3 'primer; 5 '-TGCATTTCT-CAAATGCCCTAATCCG-3'; amplified fragment: 681 bp. Primers for human IL-7 receptor were: 5'primer; 5'-AAAGTGGCTATGCTC-AAAATGGAGACTTGG-3'; 3 'primer; 5 '-TTCCCGATAGATGAC-ACTCAGGTCAAAAGG-3'; amplified fragment: 362 bp. Primers for G3PDH were: 5'primer; 5'-TGAAGGTCGGAGTCAACGGAT-TTGGT-3'; 3 'primer; 5 '-CATGTGGGCCATGAGGTCCACCAC-3'; amplified fragment: 983 bp, (Mapping Amplimers; Clontech) used as controls. For PCR, 5 yd of cDNA was amplified in the presence of 0.5 tiM each of the 5' and 3' primers, 0.5 U of Thermus aquaticus (Taq) DNA polymerase (Ampli Taq; Perkin-Elmer Cetus Instruments). PCR was performed in a DNA thermal cycler for 30 cycles (94°C for 45 s, 60°C for 45 s, and 72°C for 90 s) followed by a 7-min extension at 72°C. 9 ,ul of the PCR products was subjected to electrophoresis on 1.6% agarose gels and stained with 0.5 ,g/ml ethidium bromide. 100bp DNA ladder (GIBCO BRL) was used as a marker. The specificity of the PCR products was validated by restriction enzyme digestion and Southern blot hybridization. The amplified IL-7 PCR product (681 bp) was digested by restriction enzyme DraI (10 U/pl, 5' TTT/AAA 3'; GIBCO BRL) into fragments. The predicted size of three fragments is 248, 230, and 203 bp.
For Southern blot, PCR products on the agarose gels were blotted onto nylon membrane (Biodyne; Pall Corp., Glen Cove, NY), and hybridized with IL-7 and IL-7 receptor gene-specific cDNA oligonucleotide probe (Clontech) labeled by digoxigenin (dig)-dUTP using the dig oligonucleotide 3'-end labeling kit (Boehringer Mannheim Biochemicals, Indianapolis, IN). The sequence for human IL-7 probe was: 5' AGTGCAGTTCAACAGTATTGTTGTGCCTTC 3' (738-709) and that for human IL-7 receptor was: 5' GGTGTTGACATCTGGGTCCT 3' (220-201). Hybridizations were done at 42°C for 18 h in a solution containing 50% formamide, 5 x SSC, 0.02% SDS, 0.1% N-lauroyl sarcosine and heat-denatured dig-l1-dUTP probe at 10 ng/ml. Blots were washed at a final stringency of 2 x SSC at 68°C and processed for detection of digoxigenin-labeled oligonucleotide probes by ELISA (anti-digoxigenin antibody linked to alkaline phosphatase) using the dig nucleic acid luminescent kit (Boehringer Mannheim Biochemicals), according to the manufacturer's instructions. Subsequently, the membrane was equilibrated and then placed in a dark box containing lumino-gen purified protein derivative. The membrane was incubated for 20 min at 370C and exposed for 15 min at room temperature. Negative controls (no DNAs) were incubated in each experiment and samples run concurrently with control samples.
Immunohistochemistry for detection of IL-7 and IL-7 receptor proteins. Frozen sections of normal human intestinal mucosa were fixed with 2% periodate lysine paraformaldehyde. After blocking nonspecific binding sites, 6-jsm sections were incubated with purified rabbit antihuman IL-7 IgG antibody (polyclonal, 10 jig/ml; Collaborative Research Inc., Lexington, MA) or purified rabbit IgG (10 ag/ml, negative control). Sections were also stained with anti-human 11L-7 receptor mAb (clone M29, IgG2b; Genzyme Corp., Cambridge, MA) or isotypematched control antibody (clone 49.2 IgG2b; PharMingen, San Diego, CA). The sections were then reacted with biotinylated goat anti-rabbit IgG and goat anti-mouse IgG, respectively, and incubated with Strep-toAvidin-enzyme conjugates (Vectastain ABC kit; Vector Laboratories Inc., Burlingame, CA). The localization of IL-7 or IL-7 receptor was visualized by the incubation with diaminobenzidine solution and counterstained with methylgreen.
In situ hybridization for detection of IL-7 and IL-7 receptor mRNA. 6-ptm cryosections of normal human intestinal mucosa were fixed with 4% paraformaldehyde and investigated using digoxigenin-labeled probes and the in situ hybridization kit (Oncor Inc., Gaithersburg, MD) as previously described (16) . IL-7 mRNA was detected with an antisense oligonucleotide of 30 bases in length; 5' AGTGCAGTTCAACAGTAT-TGTTGTGCCTTC 3'. As a negative control probe we used synthetic sense strand IL-7 probe 30-mer oligonucleotide; 5' GAAGGCACAACA-ATACTGTTGAACTGCACT 3'. IL-7 receptor mRNA was detected with an antisense oligonucleotide of 40 bases in length; 5' GGTTCAATG-TCAGGATTICCAGATTGGAGAGAAAATGGAGG 3'. As a negative control probe we used the synthetic sense strand IL-7 receptor probe 40-mer oligonucleotide; 5' CCTCCATTITCTCTCCAATCTGGAATC-CTGACATTGAACC 3'. Bound digoxigenin-labeled probes were visualized using an antidigoxigenin antibody (Boehringer Mannheim Biochemicals) conjugated to alkaline phosphatase and 5-bromo-chloro-3-indoylphosphate as a substrate.
Preparation of mucosal lymphocytes from the intestinal mucosa. IELs and LPLs were isolated from surgically resected intestinal specimens using enzymatic techniques as previously described (22) . Briefly, the dissected mucosa was incubated with Ca++ Mg++ -free Hanks' buffered saline solution containing 1 mM dithiothreitol (Sigma Chemical Co., St. Louis, MO) to remove mucus. The mucosa then incubated four times in medium containing 0.75 mM EDTA (Sigma Chemical Co.). The supernatants from these incubations containing IEL population and LPLs were collected and incubated in medium with 0.02% collagenase (Worthington Biochemical Corp., Freehold, NJ) and 0.01% DNase (Worthington Biochemical Corp.). The fraction was pelleted twice through a 40% isotonic Percoll solution and the cells were centrifuged over Ficoll-Hypaque density gradient. The purity of resulting IELs and LPLs was analyzed by flow cytometry. Cell preparations were adequately pure, since a/,63 T cells made up 82-96% of the CD3 + cells in LPL and 72-92% in IELs, the fraction of HML-1+ (directed to a molecule expressed on many epithelial lymphocytes including 90% of human IELs, kindly provided by M. Brenner, Dana-Farber Cancer Institute, Boston, MA) cells was > 90% in all IELs, and the CD4/CD8 ratio was < 0.1 in IELs and > 2.2 in LPLs. They were used for further experiments immediately or after culture in medium (RPMI 1640 supplemented with 10% FCS, penicillin-streptomycin-fungizone, gentamycin, Hepes buffer).
Paired PBLs were also isolated by Ficoll-Hypaque density gradient. Flow cytometry. mAbs used included anti-CD3, anti-CD4, and anti-CD8a (Leu-4, Leu-3a, and Leu-2a, respectively; Becton Dickinson and Co., Mountain View, CA). Anti-T cell receptor (TcR) a//3 (Identi-T Pan-TcR a/3) and anti-6 chain of TcR y/6 (Identi-T 6TCS1 and Diversi-T 6V2 [a]) were obtained from T Cell Sciences, Inc. (Cambridge, MA). Purified rabbit anti-human IL-7 IgG antibody and anti-human IL-7 receptor mAb (clone M29) were also used. Flow cytometric two-color analysis carried out as described (23) 
Results
Normal human intestinal epithelial cells express IL-7 mRNA and produce IL-7 protein. Reverse transcription-PCR analysis demonstrated IL-7 mRNA expression in normal human colonic tissues. The specificity of amplified bands was validated by their predicted size (681 bp). To ensure the correct predicted fragments are present, we digested the amplified IL-7 PCR product by restriction enzyme DraL. As shown in Fig. 1 A, 681 bp PCR product from normal human colonic mucosa was digested into three predicted fragments with 248, 230, and 203 bp. Southern blot analysis confirmed the expression of IL-7 mRNA in the human colonic mucosa (Fig. 1 B) . IL-7 mRNA expression was detected in the colon, and a detectable expression of IL-7 was at other sites in the gastrointestinal tract. Equivalent hybridization was observed in Southern blot analyses using cDNA prepared from seven separate sets of tissue samples. IL-7 mRNA was not readily detectable in the normal human thymus tissues as previously reported (15) .
Immunohistochemical analysis using an anti-human IL-7 was detected in the colon, but was only barely detectable at other sites in the gastrointestinal tract. Note that IL-7 mRNA was not readily detectable in normal human thymus tissues as reported (15) , in contrast to the constitutive G3PDH mRNA was. PCR products were blotted onto nylon membrane and hybridized with IL-7 gene-specific cDNA oligonucleotide probe labeled with digoxigenin. The specificity of the amplified bands for IL-7 was validated by their predicted size (681 bp). Markers represented 100-bp DNA ladder. SK-HEP-1, the cell line that was used to clone the cDNA for the human IL-7, served as a positive control. For internal standard, amplified bands for G3PDH were used as the house-keeping gene.
mAb confirmed IL-7 expression in the human intestinal epithelial cells. As shown in Fig. 2 A, the reactivity of the anti-human IL-7 IgG antibody, but not rabbit IgG, was confined to colonic epithelial cells and epithelial goblet cells in normal human intestinal mucosal tissues. We also used in situ hybridization, which clearly yielded IL-7 mRNA expression in the intestinal epithelial cells in the saggital, as well as cross section of colonic tissues. As shown in Fig. 2 B, in situ hybridization demonstrated that all intestinal epithelial cells stained positively, but the strongly positive staining cells are intestinal goblet cells in the mucosa. These results suggested that IL-7 protein is produced by human intestinal epithelial cells and may be accumulated in the mucin glycoprotein in the goblet cells. Normal human intestinal mucosal lymphocytes express IL-7 receptor on the cell surface. Since IL-7 has previously been shown to stimulate the growth of T cell progenitors in mouse thymus and fetal liver (9), we sought to determine whether locally produced IL-7 in the intestinal mucosa affects mucosal lymphocytes. We first studied 11L-7 receptor expression in IELs and LPLs. Immunohistochemical analysis demonstrated that both LPLs and IELs in the normal human colonic mucosa express the receptor for IL-7 ( Fig. 3 A) . We also used in situ hybridization, which yielded IL-7 receptor mRNA expression in the intestinal mucosal lymphocytes in normal colonic mucosa ( Fig. 3 B) .
We then isolated mucosal lymphocytes from human colonic tissue, and studied the expression of IL-7 receptor mRNA and cell surface expression of IL-7 receptor. As shown in Fig. 4 , PCR and Southern blot analysis demonstrated IL-7 receptor mRNA in the LPLs of normal intestinal mucosa. The specificity of amplified bands was validated by their predicted size (362 bp). Interestingly, human colonic epithelial cell lines, Caco-2, also expressed IL-7 receptor mRNA. However, the human colonic epithelial cell line, HT29-18-N2, expressed no detectable expression of IL-7 receptor. The cell surface expression of IL-7 receptor by mucosal lymphocytes was confirmed by using flow cytometric analysis of freshly isolated LPLs (Fig. 5 ). On the contrary, IL-7 receptor was not found in freshly isolated PBLs obtained from the same individuals (Fig. 5 ), though those PBLs were shown to express IL-7 mRNA by Southern blot hybridization (Fig. 4 ). IL-7 regulates the proliferation ofhuman intestinal mucosal lymphocytes. Subsequently, functional activity of IL-7 receptor was assessed by the utility of exogenous recombinant IL-7 (rL-7) to stimulate the growth of freshly isolated intestinal mucosal lymphocytes. rIL-7 alone stimulated a significant increase in DNA synthesis in freshly isolated LPLs from seven different individuals ( Fig. 6 A [a] ). A determination of cell yield in LPL cultures verified that the addition of rIL-7 alone caused an increase in cell recovery (Fig. 6 A [c] ). However, rIL-7 inhibited anti-CD3 mAb-induced DNA synthesis and proliferative responses of LPLs in a dose-dependent fashion ( Fig. 6 A [b] ).
The number of cells in LPL cultures after stimulation with rIL-7 and anti-CD3 mAb was significantly decreased, compared to cultures established with anti-CD3 mAb alone ( Fig. 6 A [c] ). These results contrasted with the proliferative responses of freshly isolated PBLs obtained from the same individual. Freshly isolated PBLs from the same patients obtained at the time of endoscopy showed no significant increase in DNA synthesis or cell yield after stimulation with rIL-7 alone (Fig. 6 B,  [a and c] ). However, the DNA synthesis and the number of PBL in culture after stimulation with rIL-7 and anti-CD3 mAb significantly increased ( Fig. 6 B, [b and c] ). Since previous studies have also shown that IL-7 is not directly mitogenic on peripheral blood T cells in short time culture (14) , our results suggest that IL-7 acts quite differently on mucosal and peripheral lymphocytes. Finally, the surface expression of lymphocyte-associated molecules was assessed on rIL-7-stimulated LPLs in the nor-mal human intestinal mucosa by flow cytometry. These cells were 95% TcRa//3+, 5% TcR-y/6', 60% CD8a', and 40%
CD4, no different from the phenotype of freshly isolated normal LPLs as reported. Interestingly, cell surface expression of CD3 in LPLs stimulated with anti-CD3 mAb + rIL-7 was significantly decreased compared with that in LPLs stimulated with anti-CD3 mAb alone (Fig. 7 a) . Relative mean fluorescence of CD3 expression in anti-CD3 mAb + IL-7 stimulated LPLs was decreased from 145±17 (that in anti-CD3 mAb-stimulated LPLs) to 81±6, though that of TcRa/,6 expression was unchanged. This result also contrasted with the case of freshly isolated PBLs where mean fluorescence of CD3 expression was rather increased in anti-CD3 mAb + IL-7 stimulated PBLs (170±8) compared with that in anti-CD3 mAb-stimulated PBLs (162±3). This result is comparable to the findings that rIL-7 inhibited anti-CD3 mAb-induced DNA synthesis and proliferative responses of freshly isolated LPLs, but not PBLs.
Discussion
11L-7 was originally described as a growth factor for precursor B cells (9) (10) (11) . Subsequent in vitro studies have demonstrated that 11L-7 is also a potent costimulus for both murine and human, immature and mature cells of the T cell lineage ( 12-15). More- over, IL-7 enhances the generation of cytotoxic T cells (24), lymphokine-activated killer cells (24, 25) , and induces proinflammatory cytokine secretion and tumoricidal activity of peripheral blood monocytes (26) . In mice, abundant IL-7 mRNA expression has been demonstrated in bone marrow stromal cells, thymus, spleen, liver, kidney, and keratinocytes (9, 16, 27) . However, in the human tissues, the localization of 11L-7 expression is not yet clearly defined. Recent studies have shown that IL-7 is expressed in human thymus, spleen, and keratinocytes ( 15, 16) , though a potential role of 11L-7 in peripheral lymphoid tissues remains unclear. In the present study we demonstrated the presence of IL-7 mRNA and 1L-7 protein expression in human intestinal epithelium. Immunohistochemical and in situ hybridization analysis of intestinal mucosa have demonstrated that the epithelial goblet cells are the likely major source of 1L-7 in their tissues. Recent studies have demonstrated that interactions between mucosal lymphocytes and intestinal epithelial cells are crucial for maintaining mucosal immunity. In fact, CDld expressed on intestinal epithelial cells was shown to be an important ligand for CD8+ mucosal T cell-epithelial cell interactions (4) . It has been also reported that cytokines released from mucosal mononuclear cells affect intestinal epithelial cell differentiation (7, 8) . However, the signals from the epithelium to mucosal lymphocytes remain to be defined. In this study we provide evidence that IL-7 may regulate the proliferation and functional differentiation of mucosal lymphocytes. It has been shown that IL-7 induces an increase in TcRa/3+ CD4-CD8-T cells in the lymph node and spleen of athymic nude mice (28) . IL-7 has also been shown to be an essential cofactor for V(D)J rearrangement of the TcRP gene in precursor T cells (29) . with thymic epithelial cells, leading to in situ TcR rearrangement of extrathymically derived T cells (30) . In concert with our results that the intestinal epithelium produces IL-7, these results suggest that IL-7 may serve as a regulatory factor for the differentiation of intestinal mucosal lymphocytes.
How does locally produced IL-7 regulate mucosal lymphocytes? Localization of the IL-7 receptor, like that of IL-7 itself, has not been well defined in human tissues. In this study, immunohistochemical analysis and Southern blot hybridization demonstrated that LPLs in the normal human colonic mucosa expressed the receptor for IL-7. The cell surface expression of IL-7 receptor by mucosal lymphocytes was confirmed by using flow cytometric analysis of freshly isolated LPLs. In contrast, IL-7 receptor was not found on the cell surface of freshly isolated PBLs, though those PBLs were shown to express IL-7 mRNA by Southern blot hybridization. Previous studies have shown that IL-7 stimulates the proliferation of human mature T cells only after exogenous stimulation in short-term culture (13, 14) . Our result, in concert with these findings, suggests that IL-7 receptor protein on the cell surface are not expressed by resting PBLs, but expressed by those PBLs after activation. Therefore, our results indicate that mucosal lymphocytes may be activated with continuous stimulation by a number of microbial or self antigens, and express IL-7 receptor. We have also demonstrated that rIL-7 alone stimulates a significant increase in DNA synthesis, and causes an eventual increase in cell recovery of isolated mucosal lymphocytes. Unexpectedly, rIL-7 inhibited anti-CD3 mAb-induced DNA synthesis and proliferative LPLs Days After Culture PBLs Days After Culture responses of LPLs in a dose-dependent fashion. The number of cells in LPL cultures after stimulation with rIL-7 and anti-CD3 mAb were significantly decreased, compared with those in the culture with rIL-2 alone, rIL-7 alone, or rIL-7 and mitogens. These results differed significantly from those seen in proliferative responses of PBLs. IL-7 acted synergistically with anti-CD3 stimulation for the induction of the proliferation of human mature T cells and tumor-infiltrating lymphocytes from renal cell carcinoma (31) . These results also suggest that 1L-7 may stimulate mucosal lymphocytes in a different fashion from PBLs. It is possible that IL-7 may inhibit the proliferation of mucosal cells after certain stimulation.
The importance of IL-7 as a mediator of local inflammatory responses remains unclear. Recent evidence suggests that IL-7 up-regulates the expression of macrophage-derived cytokines such as IL-8, TNF, IL-1, and IL-6 and may function as an important proinflammatory cytokine (32) . A possible role for IL-7 in mucosal inflammation has been suggested recently by the finding of altered IL-7 mRNA expression in the colonic epithelium in inflamed mucosa of patients with ulcerative colitis (Watanabe, M., unpublished data). Interestingly, IL-7 receptor expression was quite marked in the mucosal lymphocytes in severely inflamed colonic mucosa from patients with ulcerative colitis. These results favor the idea that IL-7 produced by intestinal epithelial cells may be involved in mucosal inflammation. 
